NovoCure Ltd (NVCR)

63.34 -2.94  -4.44% NASDAQ Apr 3, 20:00 Delayed 2m USD

NovoCure Cash from Financing (TTM):

61.68M for Dec. 31, 2019
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 61.68M
Sept. 30, 2019 55.66M
June 30, 2019 44.09M
March 31, 2019 34.62M
Dec. 31, 2018 69.37M
Sept. 30, 2018 68.13M
June 30, 2018 65.94M
March 31, 2018 56.82M
Dec. 31, 2017 5.168M
Sept. 30, 2017 5.167M
June 30, 2017 76.31M
March 31, 2017 75.14M
Dec. 31, 2016 75.12M
Sept. 30, 2016 235.05M
June 30, 2016 160.76M
March 31, 2016 253.24M
Dec. 31, 2015 276.99M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Abbott Laboratories -4.289B
Amgen Inc -15.77B
Immunogen Inc 2.873M

Cash from Financing (TTM) Range, Past 5 Years

Minimum 5.167M Sep 2017
Maximum 276.99M Dec 2015
Average 95.25M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.